{
  "company": {
    "name": "ExeVir",
    "website": "https://exevir.com/",
    "record": "https://startuphistory.org/c/exevir.com"
  },
  "status": null,
  "history_since": "2020-08-06T21:11:04.000Z",
  "baseline": {
    "snapshot_id": "4a9e0bd981d8451b8bc4d620683ce15b73ad4630056f22b802855de6cf8f77d7",
    "observed_at": "2020-08-06T21:11:04.000Z",
    "headline": "RAPID VIRAL CONTROL IN A WORLD THAT NEEDS IT",
    "description": "Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development",
    "evidence": "https://web.archive.org/web/20200806211104/https://exevir.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T14:09:01.664Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-05T14:09:01.664Z",
      "variants": [
        {
          "headline": "RAPID VIRAL CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development",
          "observed_at": "2020-08-06T21:11:04.000Z",
          "evidence": "https://web.archive.org/web/20200806211104/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "RAPID VIRAL CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development",
          "observed_at": "2021-01-05T23:37:04.000Z",
          "evidence": "https://web.archive.org/web/20210105233704/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "RAPID VIRAL CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development",
          "observed_at": "2021-07-24T06:42:40.000Z",
          "evidence": "https://web.archive.org/web/20210724064240/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "RAPID VIRAL CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development",
          "observed_at": "2022-07-07T00:36:45.000Z",
          "evidence": "https://web.archive.org/web/20220707003645/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development",
          "observed_at": "2023-01-10T09:23:56.000Z",
          "evidence": "https://web.archive.org/web/20230110092356/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases. ExeVir develops novel ",
          "observed_at": "2023-10-01T02:20:08.000Z",
          "evidence": "https://web.archive.org/web/20231001022008/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases. ExeVir develops novel ",
          "observed_at": "2024-01-04T09:14:53.000Z",
          "evidence": "https://web.archive.org/web/20240104091453/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases.",
          "observed_at": "2025-01-13T15:54:00.000Z",
          "evidence": "https://web.archive.org/web/20250113155400/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases.",
          "observed_at": "2025-07-24T14:45:17.000Z",
          "evidence": "https://web.archive.org/web/20250724144517/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases.",
          "observed_at": "2025-07-28T02:50:35.000Z",
          "evidence": "https://web.archive.org/web/20250728025035/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases.",
          "observed_at": "2025-11-02T15:23:22.000Z",
          "evidence": "https://web.archive.org/web/20251102152322/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases.",
          "observed_at": "2026-01-20T20:30:09.000Z",
          "evidence": "https://web.archive.org/web/20260120203009/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases.",
          "observed_at": "2026-06-17T03:10:17.000Z",
          "evidence": "https://web.archive.org/web/20260617031017/https://exevir.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
          "subhead": "The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases.",
          "observed_at": "2026-11-05T14:09:01.664Z",
          "evidence": "https://exevir.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "INFECTIOUS DISEASE CONTROL IN A WORLD THAT NEEDS IT",
      "subhead": "The growing world population and climate change give rise to increasing incidences and rapidly spreading infectious diseases.",
      "from": "2020-08-06T21:11:04.000Z",
      "to": "2026-11-05T14:09:01.664Z",
      "captures": 14,
      "evidence": "https://exevir.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2020-08-06T21:11:04.000Z",
          "to": "2026-11-05T14:09:01.664Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-2034f7c82c163c02405d7cd747681a32f4933bbf514e11d705e482cae7964b51:96f5e0f0d3d1e64cd575c3cb69c088a8e15da414b91cf7d9682a7c0e7d195b7d:funding:23aa1cccf5d4bd50",
      "before_evidence": "https://web.archive.org/web/20220707003645/https://exevir.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “ExeVir has also raised €16.5 million in non-dilutive funding from Horizon Europe, VLAIO, and the DG06.”.",
      "between": {
        "from": "2022-07-07T00:36:45.000Z",
        "to": "2023-01-10T09:23:56.000Z"
      },
      "evidence": "https://web.archive.org/web/20230110092356/https://exevir.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-2034f7c82c163c02405d7cd747681a32f4933bbf514e11d705e482cae7964b51:96f5e0f0d3d1e64cd575c3cb69c088a8e15da414b91cf7d9682a7c0e7d195b7d:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20220707003645/https://exevir.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2022-07-07T00:36:45.000Z",
        "to": "2023-01-10T09:23:56.000Z"
      },
      "evidence": "https://web.archive.org/web/20230110092356/https://exevir.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “ExeVir” company record, https://startuphistory.org/c/exevir.com"
}